文献速递生殖医学

子宫内膜因素检测是临床不孕症管理的有用工具

Endometrial factor testing is a useful tool in clinical infertility management.
PubMed 文献 · Reprod Biomed Online · 2021-12-25

本文论述将转录组学应用于子宫内膜生物学可客观识别胚胎着床的个体化窗口期,16S rRNA基因测序可识别子宫内膜共生微生物并将其组成与IVF患者生殖结局相联系,强调子宫内膜因素检测对个体化生殖诊疗的临床意义,认为子宫内膜因素的通用化医疗时代将终结并被个体化诊疗取代。

要点

  • 转录组学应用于子宫内膜生物学可客观识别个体化的胚胎着床窗口期。
  • 16S rRNA基因测序可识别子宫内膜共生微生物,其组成与IVF患者生殖结局相关。
  • 子宫内膜因素检测对个体化生殖诊疗具有临床意义,通用化医疗将被个体化诊疗取代。

核心结论

  • 子宫内膜因素检测有助于个体化生殖诊疗,子宫内膜因素的通用化医疗时代将终结并被个体化诊疗取代以改善结局。

研究设计与样本

  • 本文为论述性文章,围绕转录组学与16S rRNA基因测序在子宫内膜因素检测中的应用展开。

主要发现

  • 将转录组学应用于子宫内膜生物学可客观识别母体子宫内膜对胚胎具有容受性的个体化时期,即着床窗口期。
  • 16S rRNA基因测序可识别定植于子宫内膜的共生微生物,并将其组成与接受IVF患者的生殖结局相联系。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Progress in medicine depends on new technologies and countercurrent concepts that translate to practice to solve long-standing problems. The application of transcriptomics to endometrial biology enables an objective identification of the personalized period during which the maternal endometrium is receptive to an embryo, known as the window of implantation. Likewise, 16S rRNA gene sequencing of microorganisms allows the identification of commensal microbes colonizing the endometrium, linking their composition with reproductive outcomes in patients undergoing IVF. Together, this knowledge underscores the clinical implication of endometrial factor testing for personalizing reproductive care. With such exciting developments and more to come, the era of generalized medicine for the endometrial factor will come to an end and will be replaced by individualized care to improve outcomes.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Simón C. Endometrial factor testing is a useful tool in clinical infertility management. Reprod Biomed Online. 2021. PMID: 35221254. doi:10.1016/j.rbmo.2021.12.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。